Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naoxintong Capsule for ischemic stroke with qi deficiency and blood stasis syndrome
ChiCTR1800015189Phase 4Recruiting
- Sponsor
- Zhejiang Hospital of Traditional Chinese Medicine
- Start
- May 2018
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of naoxintong in ischemic stroke (4 arms), sponsored by Zhejiang Hospital of Traditional Chinese Medicine. Primary endpoint: NIHSS. Started May 2018; status: recruiting.
02
Drugs
naoxintong
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR1800015189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800015189.